Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The unique properties of IgG4 and its roles in health and disease
Theo Rispens, Maartje G. Huijbers
Nature reviews. Immunology (2023) Vol. 23, Iss. 11, pp. 763-778
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Impact of structural modifications of IgG antibodies on effector functions
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 30
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
Shouyan Deng, Yibo Zhang, Huanbin Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2305-2323.e33
Closed Access | Times Cited: 14
Theoretical and practical considerations for validating antigen-specific B cell ImmunoSpot assays
Paul Lehmann, Alexey Y. Karulin, Noémi Becza, et al.
Journal of Immunological Methods (2025), pp. 113817-113817
Open Access | Times Cited: 2
Selective Protein (Post-)modifications through Dynamic Covalent Chemistry: Self-activated SNAr Reactions
Ferran Esteve, J.‐L. Schmitt, Sergii Kolodych, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 29
Waning immunity and IgG4 responses following bivalent mRNA boosting
Ninaad Lasrado, Ai‐ris Y. Collier, Jessica Miller, et al.
Science Advances (2024) Vol. 10, Iss. 8
Open Access | Times Cited: 13
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19
Bindu Adhikari, Joseph S. Bednash, Jeffrey C. Horowitz, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeys
Madeline M. Vroom, Hanxin Lu, Maggie Lewis, et al.
Journal of Lipid Research (2024) Vol. 65, Iss. 2, pp. 100497-100497
Open Access | Times Cited: 9
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer–BioNTech Vaccine
Ana M. Espino, Albersy Armina-Rodríguez, Laura Alvarez, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 187-187
Open Access | Times Cited: 9
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants
Shilpi Jain, Sanjeev Kumar, Lilin Lai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
Current and future advances in practice: IgG4-related disease
Zachary S. Wallace, Guy Katz, Yasmin G. Hernandez‐Barco, et al.
Rheumatology Advances in Practice (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 8
Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines
Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106119-106119
Open Access | Times Cited: 7
Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease
Asami Nishikori, Midori Filiz Nishimura, David C. Fajgenbaum, et al.
Journal of Clinical Pathology (2024), pp. jcp-209280
Closed Access | Times Cited: 5
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
G Pastore, Jacopo Polvere, Fabio Fiorino, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 432-444
Open Access | Times Cited: 5
Mechanisms of autoimmune encephalitis
Claudia Papi, Chiara Milano, Marianna Spatola
Current Opinion in Neurology (2024) Vol. 37, Iss. 3, pp. 305-315
Closed Access | Times Cited: 5
Pharmacological Management of IgG4-Related Disease: From Traditional to Mechanism-Based Targeted Therapies
Mitsuhiro Akiyama, Waleed Alshehri, Koichi Saito, et al.
Drugs & Aging (2025)
Closed Access
Roles of immunoglobulin GM and KM allotypes and Fcγ receptor 2 A genotypes in humoral immunity to a conserved microbial polysaccharide in pulmonary diseases
Janardan P. Pandey, Paul J. Nietert, Aryan M. Namboodiri, et al.
Genes and Immunity (2025)
Open Access
Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial
Ran Ran, Hongtao Li, Tao Sun, et al.
International Journal of Cancer (2025)
Open Access
Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant Recipients
Ignacio Juárez, Isabel Pérez-Flores, Arianne S. Aiffil Meneses, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 123-123
Open Access
Laparoscopic Resection for Colonic Obstruction Due to Immunoglobulin G4-Related Disease: A Case Report
Hitoshi Kameyama, Gen Tomizawa, Toshiyuki Yamazaki, et al.
Cureus (2025)
Open Access
High risk of asthma among early teens is associated with quantitative differences in mite and cat allergen specific IgE and IgG4: a modified Th2 related antibody response revisited
Thomas A.E. Platts‐Mills, Behnam Keshavarz, Jeffrey M. Wilson, et al.
EBioMedicine (2025) Vol. 112, pp. 105556-105556
Open Access
Characteristic TARC/CCL17 expression in the salivary gland of IgG4-related disease: potential diagnostic utility and insights into pathogenesis
Natsuko Kikuchi, Sae Hatanaka, Terufumi Kubo, et al.
Immunological Medicine (2025), pp. 1-7
Open Access
Editorial: T and B cell immune dynamics in allergic response
Mrinmoy Das, Tarun Keswani
Frontiers in Allergy (2025) Vol. 6
Open Access
Type 2 immunity in allergic diseases
İsmail Öğülür, Yasutaka Mitamura, Duygu Yazıcı, et al.
Cellular and Molecular Immunology (2025)
Open Access
Characterization of Anti-Insulin Antibodies in Type 1 and Type 2 Diabetes Mellitus: Clinical Relevance
Henrik Toft–Hansen, Christina Aniol-Nielsen, Daniel Elias, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1730-1730
Open Access
Page 1 - Next Page

Scroll to top